DK0379145T3 - Substituerede quinolincarboxylsyrer - Google Patents

Substituerede quinolincarboxylsyrer

Info

Publication number
DK0379145T3
DK0379145T3 DK90100839.1T DK90100839T DK0379145T3 DK 0379145 T3 DK0379145 T3 DK 0379145T3 DK 90100839 T DK90100839 T DK 90100839T DK 0379145 T3 DK0379145 T3 DK 0379145T3
Authority
DK
Denmark
Prior art keywords
carboxylic acids
quinoline carboxylic
substituted quinoline
disclosed
substituted
Prior art date
Application number
DK90100839.1T
Other languages
Danish (da)
English (en)
Inventor
John Frank Poletto
Dennis William Powell
Diane Harris Boschelli
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0379145T3 publication Critical patent/DK0379145T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
DK90100839.1T 1989-01-17 1990-01-16 Substituerede quinolincarboxylsyrer DK0379145T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/298,585 US4968702A (en) 1989-01-17 1989-01-17 Substituted quinolinecarboxylic acids

Publications (1)

Publication Number Publication Date
DK0379145T3 true DK0379145T3 (da) 1997-05-26

Family

ID=23151154

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90100839.1T DK0379145T3 (da) 1989-01-17 1990-01-16 Substituerede quinolincarboxylsyrer

Country Status (17)

Country Link
US (1) US4968702A (ko)
EP (1) EP0379145B1 (ko)
JP (1) JP3004025B2 (ko)
KR (1) KR0140076B1 (ko)
AT (1) ATE152711T1 (ko)
AU (1) AU624471B2 (ko)
CA (1) CA2007740C (ko)
DE (1) DE69030632T2 (ko)
DK (1) DK0379145T3 (ko)
ES (1) ES2100851T3 (ko)
GR (1) GR3023585T3 (ko)
HK (1) HK1008019A1 (ko)
IE (1) IE900169L (ko)
IL (1) IL92898A (ko)
NZ (1) NZ232111A (ko)
PH (1) PH26961A (ko)
ZA (1) ZA90299B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO1999038846A1 (en) * 1998-01-30 1999-08-05 Procept, Inc. Immunosuppressive agents
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) * 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
MXPA05001642A (es) * 2002-08-13 2005-04-25 Warner Lambert Co Derivados de naftaleno como inhibidores de metaloproteinasas de matriz.
US7138412B2 (en) * 2003-03-11 2006-11-21 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives useful as serine protease inhibitors
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
CA2898615A1 (en) * 2013-01-28 2014-07-31 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
KR20160079123A (ko) 2013-11-22 2016-07-05 젠자임 코포레이션 신경변성 질병을 치료하기 위한 신규한 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE287804C (ko) *
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds
FR2166297A1 (en) * 1972-01-07 1973-08-17 Rosenberg Eli 2-(4-isopropylphenyl)quinoline-4-carboxylic acid - as a non-toxic, analgesic agent
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
EP0133244B1 (en) * 1983-07-22 1990-12-05 E.I. Du Pont De Nemours And Company Phenylquinolinecarboxylic acids and derivatives as antitumor agents
EP0318093A3 (en) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylquinoline diacids and their use as medicaments

Also Published As

Publication number Publication date
IL92898A0 (en) 1990-09-17
PH26961A (en) 1992-12-28
CA2007740A1 (en) 1990-07-17
KR900011733A (ko) 1990-08-02
JP3004025B2 (ja) 2000-01-31
DE69030632D1 (de) 1997-06-12
GR3023585T3 (en) 1997-08-29
HK1008019A1 (en) 1999-04-30
DE69030632T2 (de) 1997-10-02
AU4850290A (en) 1990-07-26
US4968702A (en) 1990-11-06
KR0140076B1 (ko) 1998-06-01
AU624471B2 (en) 1992-06-11
ATE152711T1 (de) 1997-05-15
EP0379145A3 (en) 1991-07-17
EP0379145B1 (en) 1997-05-07
CA2007740C (en) 1999-12-07
JPH02229166A (ja) 1990-09-11
ES2100851T3 (es) 1997-07-01
IE900169L (en) 1990-07-17
IL92898A (en) 1994-11-28
NZ232111A (en) 1992-07-28
ZA90299B (en) 1990-10-31
EP0379145A2 (en) 1990-07-25

Similar Documents

Publication Publication Date Title
DK0379145T3 (da) Substituerede quinolincarboxylsyrer
FI914905A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
ES2058614T3 (es) 1,2-ciclohexilaminoarilaminadas utiles como agentes analgesicos.
FI104323B1 (fi) Menetelmä terapeuttisesti käyttökelpoisen 3-alkyyli-4-metyyli-4-(3-hydroksifenyyli)piperidiini-N-alkyylikarboksylaattien trans-3,4-isomeerien valmistamiseksi
GR78654B (ko)
AU6995391A (en) Intermediates in the preparation of novel bicyclic esters and amides useful as specific 5-ht3 antagonists
FI953899A0 (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
MA23610A1 (fr) Nouvelles streptogramines et procede de preparation de streptogramines par mutasynthese
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
NL980015I1 (nl) Nieuwe 2-c(2,6-dichloorfenyl)amine!fenylacetoxyacetylderivaten, werkwijze voor de bereiding ervan enhun therapeutisch gebruik.
HU904201D0 (en) Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds
ITMI920794A1 (it) Procedimento per la produzione di carbone attivo
FI890503A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-syklopropyyli-6-fluori-7-(3,3-disubstituoitu-1-pyrrolidinyyli)-1,4-dihydro-4-okso-3-kinoliinikarboksyylihappojen valmistamiseksi
FI97136B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-metoksi-10-(1-hydroksietyyli)-11-okso-1-atsatrisyklo/7.2.0.03,8/-undek-2-eeni-2-karboksyylihappojen asyylioksialkyyliestereiden valmistamiseksi
FI940869A (fi) Menetelmä karboksyylihappoanhydridien valmistamiseksi
ITMI922551A0 (it) Procedimento per la produzione di carbone attivo
DK67888D0 (da) Bicycliske beta-lactam-carboxylsyrer
ATE11410T1 (de) 17-cyclopropylmethyl-3-hydroxy-14-methoxy 7 alpha-methylmorphinan-6-on.
NO175859C (no) Fremgangsmåte for fremstilling av kinolincarboxylsyrer
ATE66453T1 (de) Herstellung von zwischenverbindungen fuer leukotrien-antagonisten.
FR2663630B1 (fr) Procede d'esterification des acides carboxyliques.
FR2616038B1 (fr) Appareil pour l'etude de la photosynthese
FI934054A (fi) Menetelmä antibakteeristen karboksyylihappojohdannaisten valmistuksessa käyttökelpoisten välituotteiden valmistamiseksi